Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |